ReviewJournal of biochemistry2026
Innate immune signalling in the adipocyte.
Review in Journal of biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Innate immune receptors detect molecular features of pathogen presence and cellular damage, enabling cells to mount anti-microbial defences including the secretion of proinflammatory cytokines. Though classically studied in immunocytes, a remarkably broad range of innate immune receptor activity is now recognized in adipocytes, including that of Toll-like receptors, NOD-like receptors, inflammasomes and nucleic acid sensors such as cGAS-STING and RIG-I. These receptors influence adipocyte proinflammatory potential through control of secreted signalling factors that act in adipose tissue. Through less well-understood mechanisms, they also influence adipocyte insulin sensitivity, lipolysis, fatty acid oxidation and thermogenesis. Innate immune receptors are activated by a diverse array of stimuli, including circulating signalling factors and intracellular metabolic stresses, especially those related to mitochondrial function. The receptors are thus a potential means by which obesity-associated signals act through adipocytes to drive inflammation, adipose dysfunction and metabolic disease pathogenesis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.